Alana Hippensteele

Monthly SC amivantamab plus daily lazertinib demonstrated strong efficacy and tolerability in EGFR-mutated advanced NSCLC, providing a convenient alternative to IV dosing.

Updated results from the MARIPOSA trial show that amivantamab plus lazertinib significantly reduces EGFR- and MET-driven resistance compared with osimertinib.

The availability of retail pharmacies throughout the country have changed the health system in terms of accessibility and treatment, explains Mark Riggle, PharmD.

Prior authorizations can affect both health system operations and worsen physician burnout.

Timothy W. Cutler, PharmD, associate chief of ambulatory care at UC Davis Health, describes how pharmacy services patients healthy and out of the hospital.

Programs such as Meds to Bed can work in tandem with retail pharmacies to offer accessible medications for patients.

UC Davis Health enhances patient care through a shared services center, ensuring continuity of care and optimizing pharmacy growth strategies.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Cancer care evolves with innovative therapies and financial challenges, emphasizing the need for equitable access and sustainable models in treatment delivery.

Key Takeaways Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and patient-centered outcomes.